| Dr Wenjay Sung, DPM | |
|
301 W Huntington Dr, Suite 300, Arcadia, CA 91007-3462 | |
| (626) 821-9323 | |
| (626) 821-9325 |
| Full Name | Dr Wenjay Sung |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 17 Years |
| Location | 301 W Huntington Dr, Arcadia, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649433129 | NPI | - | NPPES |
| E5032 | Other | CA | CA LICENSE |
| 016-005436 | Other | IL | PUBLIC AID ID# |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sante Home Health, Inc | Panorama city, CA | Home health agency |
| Methodist Hospital Of Southern Ca | Arcadia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chugo E. Rinoie Dpm Corp. | 2668559592 | 2 |
News Archive
Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.
Anacor Pharmaceuticals announced today that on July 26, 2013 it submitted its New Drug Application to the U.S. Food and Drug Administration for tavaborole, its drug candidate for the topical treatment of onychomycosis. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"
"Representatives of the United Nations Children's Fund, the U.S. Agency for International Development and the Bill & Melinda Gates Foundation attended the world's first global newborn health conference in Johannesburg on Monday," Business Day Live reports (Magubane/Rapetswane, 4/15).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
› Verified 1 days ago
| Provider Name | Cambridge Foot And Ankle Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1730180266 PECOS PAC ID: 5890744619 Enrollment ID: O20050119000791 |
News Archive
Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.
Anacor Pharmaceuticals announced today that on July 26, 2013 it submitted its New Drug Application to the U.S. Food and Drug Administration for tavaborole, its drug candidate for the topical treatment of onychomycosis. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"
"Representatives of the United Nations Children's Fund, the U.S. Agency for International Development and the Bill & Melinda Gates Foundation attended the world's first global newborn health conference in Johannesburg on Monday," Business Day Live reports (Magubane/Rapetswane, 4/15).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
› Verified 1 days ago
| Provider Name | Chugo E. Rinoie Dpm Corp. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043331820 PECOS PAC ID: 2668559592 Enrollment ID: O20080402000767 |
News Archive
Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.
Anacor Pharmaceuticals announced today that on July 26, 2013 it submitted its New Drug Application to the U.S. Food and Drug Administration for tavaborole, its drug candidate for the topical treatment of onychomycosis. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"
"Representatives of the United Nations Children's Fund, the U.S. Agency for International Development and the Bill & Melinda Gates Foundation attended the world's first global newborn health conference in Johannesburg on Monday," Business Day Live reports (Magubane/Rapetswane, 4/15).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wenjay Sung, DPM 301 W Huntington Dr, Suite 300, Arcadia, CA 91007-3462 Ph: (626) 821-9323 | Dr Wenjay Sung, DPM 301 W Huntington Dr, Suite 300, Arcadia, CA 91007-3462 Ph: (626) 821-9323 |
News Archive
Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.
Anacor Pharmaceuticals announced today that on July 26, 2013 it submitted its New Drug Application to the U.S. Food and Drug Administration for tavaborole, its drug candidate for the topical treatment of onychomycosis. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"
"Representatives of the United Nations Children's Fund, the U.S. Agency for International Development and the Bill & Melinda Gates Foundation attended the world's first global newborn health conference in Johannesburg on Monday," Business Day Live reports (Magubane/Rapetswane, 4/15).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, reports continued progress in its compassionate use program for PV-10. The program currently has enrolled more than 40 patients, ten of whom are expanded access patients from the company's Phase 2 trial of PV-10 for metastatic melanoma, as well as more than 30 new patients.
› Verified 1 days ago
Dr. Jimmy Lee, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 624 W Duarte Rd Ste 105, Arcadia, CA 91007 Phone: 626-446-1740 Fax: 626-446-6287 | |
Chugo E. Rinoie Dpm Corp. Podiatrist Medicare: Medicare Enrolled Practice Location: 301 W Huntington Dr Ste 300, Arcadia, CA 91007 Phone: 626-821-9323 Fax: 626-821-9325 | |
Vantage Foot And Ankle Center Podiatrist Medicare: Medicare Enrolled Practice Location: 550 W Duarte Rd Ste 5, Arcadia, CA 91007 Phone: 626-538-4505 | |
Dr. David Kim Bae, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 301 W Huntington Dr, Suite 300, Arcadia, CA 91007 Phone: 626-821-9323 Fax: 626-821-9325 | |
Dr. Daniel Christopher Barry, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 450 E Huntington Dr, Arcadia, CA 91006 Phone: 626-462-1884 | |
Lily Y Lin, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 450 E Huntington Dr, Arcadia, CA 91006 Phone: 626-254-2175 Fax: 626-445-5034 | |
Dr. Susan Heidi Kirkpatrick, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 20 E Huntington Dr, Arcadia, CA 91006 Phone: 626-574-7592 Fax: 626-447-3704 |